Cite
Phase II and III Clinical Studies of Diphtheria-Tetanus-Acellular Pertussis Vaccine Containing Inactivated Polio Vaccine Derived from Sabin Strains (DTaP-sIPV).
MLA
Okada, Kenji, et al. “Phase II and III Clinical Studies of Diphtheria-Tetanus-Acellular Pertussis Vaccine Containing Inactivated Polio Vaccine Derived from Sabin Strains (DTaP-SIPV).” Journal of Infectious Diseases, vol. 208, no. 2, July 2013, pp. 275–83. EBSCOhost, https://doi.org/10.1093/infdis/jit155.
APA
Okada, K., Miyazaki, C., Kino, Y., Ozaki, T., Hirose, M., & Ueda, K. (2013). Phase II and III Clinical Studies of Diphtheria-Tetanus-Acellular Pertussis Vaccine Containing Inactivated Polio Vaccine Derived from Sabin Strains (DTaP-sIPV). Journal of Infectious Diseases, 208(2), 275–283. https://doi.org/10.1093/infdis/jit155
Chicago
Okada, Kenji, Chiaki Miyazaki, Yoichiro Kino, Takao Ozaki, Mizuo Hirose, and Kohji Ueda. 2013. “Phase II and III Clinical Studies of Diphtheria-Tetanus-Acellular Pertussis Vaccine Containing Inactivated Polio Vaccine Derived from Sabin Strains (DTaP-SIPV).” Journal of Infectious Diseases 208 (2): 275–83. doi:10.1093/infdis/jit155.